ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 112.80
+4.30 (3.96%)
Jul 31, 2026, 11:49 AM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €9.35 billion as of July 31, 2026. Its market cap has increased by 106.05% in one year.
Market Cap
9.35B
Enterprise Value
8.90B
Revenue
4.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
€112.80
ChartMarket Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 9.35B, an increase of 4,527.28%. That is a compound annual growth rate of 41.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 9.35B | -0.19% |
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.79B |
| MedinCell | 933.51M |
| Inventiva | 926.22M |
| DBV Technologies | 722.03M |
| Genfit | 682.33M |
| Valneva SE | 408.88M |
| Valerio Therapeutics Société anonyme | 388.57M |
| Transgene | 197.47M |